STOCK TITAN

Zoetis (ZTS) director Sanjay Khosla granted 1,936 restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zoetis Inc. director Sanjay Khosla reported an equity award in the form of restricted stock units. He acquired 1,936 RSUs on February 18, 2026 under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. Each RSU represents a contingent right to receive one share of Zoetis common stock.

The footnotes state these RSUs will vest and be settled in Zoetis common shares on the first anniversary of the grant date, February 18, 2026, subject to his continued service and certain earlier-vesting events. The filing also updates holdings from a prior RSU grant scheduled to vest on February 19, 2025.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sanjay Khosla

(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit(1) (2) 02/18/2026 A 1,936 (3) (4) Common Stock 1,936 $0 1,936 D
Restricted Stock Unit(1) (2) (5) (4) Common Stock 1,619.3325 1,619.3325 D
Explanation of Responses:
1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
2. Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.
3. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
4. Not applicable.
5. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 02/19/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Zoetis (ZTS) director Sanjay Khosla report in this Form 4?

Sanjay Khosla reported receiving a grant of restricted stock units. He was awarded 1,936 RSUs on February 18, 2026 under the Zoetis equity and incentive plan, each representing a contingent right to one share of Zoetis Inc. common stock upon vesting.

How many restricted stock units did Sanjay Khosla receive from Zoetis (ZTS)?

He received 1,936 restricted stock units. These RSUs were granted on February 18, 2026 under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan and will convert into the same number of Zoetis common shares after they vest, subject to service conditions.

When do Sanjay Khosla’s new Zoetis (ZTS) RSUs vest and settle?

The new RSUs vest and settle on the first anniversary of the grant date. The footnotes specify vesting and settlement in Zoetis common stock on February 18, 2026, assuming continued service and subject to earlier vesting upon certain specific events described in the award terms.

What does each Zoetis (ZTS) restricted stock unit represent for this director grant?

Each RSU represents a contingent right to receive one Zoetis Inc. common share. The units include dividend equivalent units and are granted under the company’s 2013 Equity and Incentive Plan, delivering actual shares only when vesting and settlement conditions described in the footnotes are satisfied.

Does the Zoetis (ZTS) Form 4 include information on prior RSU awards?

Yes. The filing notes RSUs scheduled to vest and settle on February 19, 2025. Those earlier RSUs follow similar terms, vesting on the first anniversary of their grant date, provided the reporting person continues service and certain specified events do not trigger earlier vesting.

Is this Zoetis (ZTS) Form 4 a stock purchase or an equity award?

This Form 4 reflects an equity award, not an open-market stock purchase. The transaction code and description identify a grant or award acquisition of 1,936 restricted stock units, issued at a stated price of $0.00 per unit as part of Zoetis’s long-term incentive program.
Zoetis Inc

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Latest SEC Filings

ZTS Stock Data

53.73B
440.24M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
PARSIPPANY